Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-09-26

FDA Approved: HYDROCODONE BITARTRATE — Supplemental Application (Alvogen Inc.)

View source ↗

Summary

FDA approved a supplemental application for hydrocodone bitartrate from Alvogen Inc. under an approved generic drug filing (ANDA).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HYDROCODONE BITARTRATE (HYDROCODONE BITARTRATE)

Snippet

SUPPL AP for HYDROCODONE BITARTRATE (HYDROCODONE BITARTRATE)